The Role of Neonatal Fc Receptor (FcRn) Blocking Therapeutics in the Management of Patients with Generalized Myasthenia Gravis

Nov 7, 2022

- Nov 6, 2023

0.75

Claim your AMA PRA Category 1 Credit

This course is available for logged in users only. Please login or register to take the course.

Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Th...

Late-Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid-Lowering Th...

Update on Long-Acting Nebulizers for Guideline-Based Maintenance Treatments for Patients w...